XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing a pipeline of differentiated therapeutics for orphan indications. Its products portfolio includes Glybera, TV-45070.

$30.77  +0.35 (1.15%)
As of 07/01/2022 15:59:58 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  Canada
IPO date:  11/05/2014
Outstanding shares:  53,105,718
Average volume:  674,558
Market cap:   $1,640,966,686
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BRJ3GY4
Valuation   (See tab for details)
PE ratio:   -19.92
PB ratio:   2.98
PS ratio:   71.83
Return on equity:   -15.28%
Net income %:   -362.39%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy